Using administrative health care data to inform cancer care policy in Canada
Using cancer registry and linked administrative health care data from BC, MB, ON, QB and NS, we propose to:
1. Examine trends in patterns of care (utilization and cost) for prostate, female breast (breast hereafter), colorectal and lung cancers during the initial and terminal phases of care in each province to understand whether/how practice and expenditures have changed over time and whether these trends differ by jurisdiction
We hypothesize that both the use and cost of chemotherapy will be increasing most rapidly over time, and we hypothesize that this trend is similar in all 5 provinces.
2. Estimate costs for the 4 most common cancer sites (prostate, breast colorectal and lung) for 4 phases of care (pre-diagnosis; initial care; continuing care; and terminal care) to understand if/why costs of care differ by province, and, if so, to determine the drivers behind potential differences
We hypothesize that terminal care costs will be highest, and the majority of costs will be from inpatient services. We hypothesize that costs will differ across provinces, though patterns across the disease groups and phases will be consistent.
3. Estimate and project the national cost of cancer care (based on data for 5 provinces) for 2012 and 2025 respectively, using the most recent available population projections and cancer incidence, survival, cost data and appropriate methodology